Clinical trials: Intestinal FDG Uptake
Intestinal FDG Uptake
A Clinical Study to Limit Physiologic Intestinal FDG Uptake Uptake on PET-CT Scans
Patients who undergo PET-CT scans to look for cancer are given an intravenous contrast (FDG) that is taken-up by active cells such as cancer cells. This contrast can then be seen in the body using the PET-CT scanner.
- Trial name
- NCT01542541
- Testing
- Rifaximin
- Where
- United States
- Volunteers
- 68 people
- Sponsor
- Beth Israel Deaconess Medical Center
Cancer
Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose)
1. Background 1. PET/CT (positron emission tomography/computed tomography) using FDG (fluorodeoxyglucose) is widely used for evaluation of cancer patients. 2.
- Trial name
- NCT02173964
- Testing
- pinaverium bromide, water
- Where
- South Korea
- Volunteers
- 58 people
- Sponsor
- Seoul National University Hospital